Ryan Awerkamp

Associate

+1 858 550 6106
rawerkamp@cooley.com

Ryan Awerkamp focuses his practice on corporate and securities matters for private and public companies, including private financings, M&A, tender offers, public offerings, corporate governance and SEC reporting and compliance.

Download full bio

Experience

  • Turning Point Therapeutics - $192 Million IPO 

  • Allogene Therapeutics – $372.6 Million IPO 

Education

  • University of Virginia School of Law
    JD, 2017

  • Brigham Young University
    BA, Economics
    magna cum laude, 2014


Admissions & Credentials

California

Media & Insight

Contact

+1 858 550 6106 office
rawerkamp@cooley.com

4401 Eastgate Mall
San Diego, CA 92121-1909